India Introduces iNCOVACC Nasal Vaccine for COVID-19 Prevention

-

On Tuesday, Bharat Biotech, the Indian pharmaceutical company known for its COVAXIN vaccine, made a major announcement concerning a new vaccine for COVID-19. The vaccine, called iNCOVACC, is the world’s first nasal vaccine for the virus, and is expected to be a major breakthrough in the fight against the pandemic.

One of the key benefits of iNCOVACC is that it does not require a needle for administration. This is a significant advantage, as many people are afraid of needles or may have medical conditions that make injections difficult or impossible. The vaccine is formulated for delivery as nasal drops, making it a painless and non-invasive option.

image of INCOVACC Nasal Vaccine

In addition to its needle-free delivery method, iNCOVACC is also intended to be a cost-effective option for immunization. It will be priced at Rs.800 plus a 5% goods and services tax (GST) in private hospitals, and Rs.325 plus a 5% GST in central and state government hospitals. This makes it an affordable option for individuals and communities in low- and middle-income countries, where access to healthcare can be limited.

Bharat Biotech developed iNCOVACC in collaboration with Washington University in St. Louis, and the vaccine is expected to be available in late January. It has already received approval for use in individuals 18 years of age and older from the Central Drugs Standard Control Organization and the Union Health Ministry. This approval allows for iNCOVACC to be administered as a primary two-dose regimen or as a heterologous booster dose, depending on the specific needs of the individual.

The slots for iNCOVACC are now open for booking on the CoWin portal, a platform designed to facilitate the distribution and administration of COVID-19 vaccines in India. This is a significant step forward in the fight against the pandemic, and people can now take the necessary steps to protect themselves and their communities from the virus.

In summary, the announcement of iNCOVACC by Bharat Biotech is a major milestone in the fight against COVID-19. The vaccine’s needle-free delivery method and cost-effective pricing make it an appealing option for individuals and communities around the world. It has already received approval for use in individuals 18 years of age and older, and slots for the vaccine are now open for booking on the CoWin portal. This is a positive development that brings us one step closer to defeating the pandemic and returning to a sense of normalcy.

Bharat Biotech, an Indian pharmaceutical company, has developed two different vaccines for COVID-19: COVAXIN and iNCOVACC. These vaccines use different platforms and have received support and guidance from government bodies, including the Union Health ministry and the Government of India’s Department of Bio Technology’s Covid Suraksha Programme. The company’s Executive Chairman, Krishna Ella, stated that the development of these vaccines was a major achievement in the fight against the pandemic.

Support Indian Spectator, follow us on Google News. Submit your opinion and guest articles on Info.indianspectator@gmail.com

Abhishek Kumar
Abhishek Kumar is a final year undergraduate student at the University of Delhi, where he is studying English Honors. He is passionate about literature and language, and enjoys researching stories. Laziest in our team and he loves coffee.

Latest News

Sukhbir Singh Sandhu and Gyanesh Kumar: The New Faces of Election Commission

In a significant turn of events, India has appointed former bureaucrats Sukhbir Singh Sandhu and Gyanesh Kumar as the...

What Exactly is IPO Financing and How Does It Impact Investment Strategies?

In the frenzied world of initial public offerings (IPOs), where the promise of substantial gains looms large, a lesser-known...

PM Modi Announces Sudha Murty’s Nomination to Rajya Sabha by President Murmu

In a big news that lines up with International Women's Day, Sudha Murthy, a well-known writer and someone who...

Top 7 Buy Now and Pay Later Application, Convenience of Easy Payments

In today's fast-paced digital world, the concept of 'Buy Now, Pay Later' (BNPL) has gained significant traction, offering consumers...

Closing Your Flipkart Pay Later Account: A Comprehensive Walkthrough

So, you've been using Flipkart, taking advantage of their Pay Later option, but now it's time to bid it...

Bihar’s Scheduled Competency Test for Newly Appointed Teachers Faces Delay

The Bihar School Examination Committee recently announced the postponement of the second session of the competency test for appointed...

PM Narendra Modi’s Deep Sea Dwarka Darshan Captured Underwater

Prime Ministe­r Narendra Modi embarked on a spiritual e­xpedition, delving into the oce­an depths to offer prayers at the­...

Damodar Savarkar: A Journey of Controversy and Conviction

You know, Vinayak Damodar Savarkar, a prominent figure in Indian politics, had quite the journey. Born on 28th May...